Laboratorio Clinico Irizarry Guasch INC
Laboratorio Clinico Irizarry Guasch INC was paid $2.00M by Medicaid between Jan 2018 and Aug 2024, across 68 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 23% of everything it billed.
LAJAS, PR 00667
Next to other Clinical Medical Laboratory providers in Puerto Rico
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,726 | $30K | |
| 2019 | 22,017 | $160K | |
| 2020 | 17,596 | $188K | |
| 2021 | 34,840 | $585K | |
| 2022 | 40,310 | $615K | |
| 2023 | 32,455 | $330K | |
| 2024incomplete | 11,567 | $91K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 23% | 10,599 | 9,499 | $450K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 14% | 11,348 | 9,900 | $276K |
| 84443 | Thyroid stimulating hormone (TSH) | 8.2% | 11,471 | 11,233 | $164K |
| 80061 | Lipid panel | 6.6% | 11,456 | 11,235 | $132K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.0% | 19,904 | 18,914 | $120K |
| 80053 | Comprehensive metabolic panel | 4.9% | 10,953 | 10,681 | $97K |
| 36415 | Collection of venous blood by venipuncture | 3.5% | 23,425 | 21,896 | $69K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.5% | 2,672 | 2,634 | $69K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 1,283 | 1,210 | $64K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.1% | 2,809 | 2,755 | $62K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.0% | 4,478 | 2,667 | $60K |
| 86328 | 2.3% | 1,829 | 1,749 | $47K |
56 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 2.3% | 5,585 | $45K |
| 81000 | 2.0% | 14,528 | $39K | |
| 82274 | 1.7% | 2,296 | $33K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 3,846 | $30K |
| 86738 | 1.4% | 2,325 | $28K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 965 | $27K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 865 | $26K |
| 84153 | 1.0% | 1,295 | $20K | |
| 84439 | <1% | 2,304 | $17K | |
| 82607 | <1% | 1,085 | $14K | |
| 82043 | <1% | 2,656 | $14K | |
| 80074 | <1% | 318 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,394 | $9K |
| 86803 | <1% | 578 | $7K | |
| 86592 | <1% | 1,763 | $7K | |
| 84436 | <1% | 1,557 | $7K | |
| 85651 | <1% | 1,643 | $5K | |
| 85730 | <1% | 934 | $5K | |
| 84479 | <1% | 1,355 | $5K | |
| 82947 | <1% | 1,100 | $4K | |
| 85610 | <1% | 968 | $3K | |
| 87088 | <1% | 409 | $3K | |
| 86360 | <1% | 66 | $3K | |
| 86706 | <1% | 295 | $3K | |
| 86708 | <1% | 245 | $3K | |
| 82570 | <1% | 478 | $2K | |
| 86038 | <1% | 146 | $2K | |
| 82950 | <1% | 338 | $1K | |
| 82728 | <1% | 124 | $1K | |
| 83001 | <1% | 83 | $1K | |
| 83655 | <1% | 115 | $1K | |
| 86140 | <1% | 363 | $1K | |
| 83540 | <1% | 165 | $960.54 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $667.29 |
| 84146 | <1% | 31 | $569.38 | |
| 80076 | <1% | 93 | $517.73 | |
| 83970 | <1% | 12 | $460.32 | |
| 84703 | <1% | 59 | $369.84 | |
| 84403 | <1% | 12 | $270.82 | |
| 87015 | <1% | 40 | $235.32 | |
| 83550 | <1% | 27 | $222.68 | |
| 82565 | <1% | 56 | $198.77 | |
| 84460 | <1% | 66 | $194.53 | |
| 80069 | <1% | 25 | $190.22 | |
| 84550 | <1% | 53 | $173.21 | |
| 84156 | <1% | 41 | $124.14 | |
| 86430 | <1% | 25 | $118.65 | |
| 82270 | <1% | 37 | $112.18 | |
| 87340 | <1% | 13 | $96.50 | |
| 84520 | <1% | 37 | $91.52 | |
| 84450 | <1% | 25 | $61.22 | |
| 85018 | <1% | 12 | $23.86 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 158 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 13 | $0.00 |
| 3044F | 0% | 127 | $0.00 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 0% | 122 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Irizarry Guasch INC | Mayaguez, PR | $1.64M |
| Laboratorio Clinico Irizarry Guasch INC | Lajas, PR | $1.53M |
| Laboratorio Clinico Irizarry Guasch INC | San Sebastian, PR | $1.50M |
| Laboratorio Clinico Irizarry Guasch INC | Mayaguez, PR | $1.24M |
| Lab Clinico Irizarry Guasch INC | Mayaguez, PR | $1.11M |
| Laboratorio Clinico Irizarry Guasch INC | San German, PR | $1.03M |
| Laboratorio Clinico Irizarry Guasch INC | Cabo Rojo, PR | $723K |
| Laboratorio Clinico Irizarry Guaschinc | Aguadilla, PR | $620K |
| Nuevo Smile Dental Care | Nuevo, CA | $546K |
| Laboratorio Clinico Irizarry Guasch INC | Aguadilla, PR | $542K |
| Laboratorio Clinico Anexo Irizarry Guasch INC | San Sebastian, PR | $353K |
| Jose M Sanchez Dental Corporation | Pomona, CA | $59K |
| Grupo Otorrinolaringologico De PR CSP | Bayamon, PR | $21K |
| Jose Manuel Sanchez MD PA | Coral Gables, FL | $62.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.